ID   TELO2_HUMAN             Reviewed;         837 AA.
AC   Q9Y4R8; D3DU73; O75168; Q7LDV4; Q9BR21;
DT   05-FEB-2008, integrated into UniProtKB/Swiss-Prot.
DT   05-FEB-2008, sequence version 2.
DT   07-APR-2021, entry version 167.
DE   RecName: Full=Telomere length regulation protein TEL2 homolog;
DE   AltName: Full=Protein clk-2 homolog;
DE            Short=hCLK2;
GN   Name=TELO2; Synonyms=KIAA0683;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; Mammalia;
OC   Eutheria; Euarchontoglires; Primates; Haplorrhini; Catarrhini; Hominidae;
OC   Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA].
RC   TISSUE=Brain;
RX   PubMed=9734811; DOI=10.1093/dnares/5.3.169;
RA   Ishikawa K., Nagase T., Suyama M., Miyajima N., Tanaka A., Kotani H.,
RA   Nomura N., Ohara O.;
RT   "Prediction of the coding sequences of unidentified human genes. X. The
RT   complete sequences of 100 new cDNA clones from brain which can code for
RT   large proteins in vitro.";
RL   DNA Res. 5:169-176(1998).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA], AND VARIANT ARG-146.
RC   TISSUE=Testis;
RX   PubMed=11230166; DOI=10.1101/gr.gr1547r;
RA   Wiemann S., Weil B., Wellenreuther R., Gassenhuber J., Glassl S.,
RA   Ansorge W., Boecher M., Bloecker H., Bauersachs S., Blum H., Lauber J.,
RA   Duesterhoeft A., Beyer A., Koehrer K., Strack N., Mewes H.-W.,
RA   Ottenwaelder B., Obermaier B., Tampe J., Heubner D., Wambutt R., Korn B.,
RA   Klein M., Poustka A.;
RT   "Towards a catalog of human genes and proteins: sequencing and analysis of
RT   500 novel complete protein coding human cDNAs.";
RL   Genome Res. 11:422-435(2001).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA], AND VARIANT ARG-146.
RC   TISSUE=Testis;
RX   PubMed=17974005; DOI=10.1186/1471-2164-8-399;
RA   Bechtel S., Rosenfelder H., Duda A., Schmidt C.P., Ernst U.,
RA   Wellenreuther R., Mehrle A., Schuster C., Bahr A., Bloecker H., Heubner D.,
RA   Hoerlein A., Michel G., Wedler H., Koehrer K., Ottenwaelder B., Poustka A.,
RA   Wiemann S., Schupp I.;
RT   "The full-ORF clone resource of the German cDNA consortium.";
RL   BMC Genomics 8:399-399(2007).
RN   [4]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RX   PubMed=11157797; DOI=10.1093/hmg/10.4.339;
RA   Daniels R.J., Peden J.F., Lloyd C., Horsley S.W., Clark K., Tufarelli C.,
RA   Kearney L., Buckle V.J., Doggett N.A., Flint J., Higgs D.R.;
RT   "Sequence, structure and pathology of the fully annotated terminal 2 Mb of
RT   the short arm of human chromosome 16.";
RL   Hum. Mol. Genet. 10:339-352(2001).
RN   [5]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RX   PubMed=15616553; DOI=10.1038/nature03187;
RA   Martin J., Han C., Gordon L.A., Terry A., Prabhakar S., She X., Xie G.,
RA   Hellsten U., Chan Y.M., Altherr M., Couronne O., Aerts A., Bajorek E.,
RA   Black S., Blumer H., Branscomb E., Brown N.C., Bruno W.J., Buckingham J.M.,
RA   Callen D.F., Campbell C.S., Campbell M.L., Campbell E.W., Caoile C.,
RA   Challacombe J.F., Chasteen L.A., Chertkov O., Chi H.C., Christensen M.,
RA   Clark L.M., Cohn J.D., Denys M., Detter J.C., Dickson M.,
RA   Dimitrijevic-Bussod M., Escobar J., Fawcett J.J., Flowers D., Fotopulos D.,
RA   Glavina T., Gomez M., Gonzales E., Goodstein D., Goodwin L.A., Grady D.L.,
RA   Grigoriev I., Groza M., Hammon N., Hawkins T., Haydu L., Hildebrand C.E.,
RA   Huang W., Israni S., Jett J., Jewett P.B., Kadner K., Kimball H.,
RA   Kobayashi A., Krawczyk M.-C., Leyba T., Longmire J.L., Lopez F., Lou Y.,
RA   Lowry S., Ludeman T., Manohar C.F., Mark G.A., McMurray K.L., Meincke L.J.,
RA   Morgan J., Moyzis R.K., Mundt M.O., Munk A.C., Nandkeshwar R.D.,
RA   Pitluck S., Pollard M., Predki P., Parson-Quintana B., Ramirez L., Rash S.,
RA   Retterer J., Ricke D.O., Robinson D.L., Rodriguez A., Salamov A.,
RA   Saunders E.H., Scott D., Shough T., Stallings R.L., Stalvey M.,
RA   Sutherland R.D., Tapia R., Tesmer J.G., Thayer N., Thompson L.S., Tice H.,
RA   Torney D.C., Tran-Gyamfi M., Tsai M., Ulanovsky L.E., Ustaszewska A.,
RA   Vo N., White P.S., Williams A.L., Wills P.L., Wu J.-R., Wu K., Yang J.,
RA   DeJong P., Bruce D., Doggett N.A., Deaven L., Schmutz J., Grimwood J.,
RA   Richardson P., Rokhsar D.S., Eichler E.E., Gilna P., Lucas S.M.,
RA   Myers R.M., Rubin E.M., Pennacchio L.A.;
RT   "The sequence and analysis of duplication-rich human chromosome 16.";
RL   Nature 432:988-994(2004).
RN   [6]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA], AND VARIANT ARG-146.
RA   Mural R.J., Istrail S., Sutton G.G., Florea L., Halpern A.L., Mobarry C.M.,
RA   Lippert R., Walenz B., Shatkay H., Dew I., Miller J.R., Flanigan M.J.,
RA   Edwards N.J., Bolanos R., Fasulo D., Halldorsson B.V., Hannenhalli S.,
RA   Turner R., Yooseph S., Lu F., Nusskern D.R., Shue B.C., Zheng X.H.,
RA   Zhong F., Delcher A.L., Huson D.H., Kravitz S.A., Mouchard L., Reinert K.,
RA   Remington K.A., Clark A.G., Waterman M.S., Eichler E.E., Adams M.D.,
RA   Hunkapiller M.W., Myers E.W., Venter J.C.;
RL   Submitted (SEP-2005) to the EMBL/GenBank/DDBJ databases.
RN   [7]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA], AND VARIANT ARG-146.
RC   TISSUE=Placenta;
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA project:
RT   the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [8]
RP   FUNCTION, AND SUBCELLULAR LOCATION.
RX   PubMed=12670948; DOI=10.1074/jbc.m300286200;
RA   Jiang N., Benard C.Y., Kebir H., Shoubridge E.A., Hekimi S.;
RT   "Human CLK2 links cell cycle progression, apoptosis, and telomere length
RT   regulation.";
RL   J. Biol. Chem. 278:21678-21684(2003).
RN   [9]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Cervix carcinoma;
RX   PubMed=18691976; DOI=10.1016/j.molcel.2008.07.007;
RA   Daub H., Olsen J.V., Bairlein M., Gnad F., Oppermann F.S., Korner R.,
RA   Greff Z., Keri G., Stemmann O., Mann M.;
RT   "Kinase-selective enrichment enables quantitative phosphoproteomics of the
RT   kinome across the cell cycle.";
RL   Mol. Cell 31:438-448(2008).
RN   [10]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=19413330; DOI=10.1021/ac9004309;
RA   Gauci S., Helbig A.O., Slijper M., Krijgsveld J., Heck A.J., Mohammed S.;
RT   "Lys-N and trypsin cover complementary parts of the phosphoproteome in a
RT   refined SCX-based approach.";
RL   Anal. Chem. 81:4493-4501(2009).
RN   [11]
RP   FUNCTION, AND INTERACTION WITH TTI1 AND TTI2.
RX   PubMed=20810650; DOI=10.1101/gad.1934210;
RA   Hurov K.E., Cotta-Ramusino C., Elledge S.J.;
RT   "A genetic screen identifies the Triple T complex required for DNA damage
RT   signaling and ATM and ATR stability.";
RL   Genes Dev. 24:1939-1950(2010).
RN   [12]
RP   INTERACTION WITH ATM; ATR; MTOR; PRKDC; RUVBL2; TTI1 AND TTI2.
RX   PubMed=20801936; DOI=10.1101/gad.1956410;
RA   Takai H., Xie Y., de Lange T., Pavletich N.P.;
RT   "Tel2 structure and function in the Hsp90-dependent maturation of mTOR and
RT   ATR complexes.";
RL   Genes Dev. 24:2019-2030(2010).
RN   [13]
RP   INTERACTION WITH TTI1; MTOR; ATM; ATR; PRKDC; SMG1 AND TRRAP.
RX   PubMed=20427287; DOI=10.1074/jbc.m110.121699;
RA   Kaizuka T., Hara T., Oshiro N., Kikkawa U., Yonezawa K., Takehana K.,
RA   Iemura S., Natsume T., Mizushima N.;
RT   "Tti1 and Tel2 are critical factors in mammalian target of rapamycin
RT   complex assembly.";
RL   J. Biol. Chem. 285:20109-20116(2010).
RN   [14]
RP   INTERACTION WITH PIH1D1.
RX   PubMed=20864032; DOI=10.1016/j.molcel.2010.08.037;
RA   Horejsi Z., Takai H., Adelman C.A., Collis S.J., Flynn H., Maslen S.,
RA   Skehel J.M., de Lange T., Boulton S.J.;
RT   "CK2 phospho-dependent binding of R2TP complex to TEL2 is essential for
RT   mTOR and SMG1 stability.";
RL   Mol. Cell 39:839-850(2010).
RN   [15]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-688, AND IDENTIFICATION BY
RP   MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Cervix carcinoma;
RX   PubMed=20068231; DOI=10.1126/scisignal.2000475;
RA   Olsen J.V., Vermeulen M., Santamaria A., Kumar C., Miller M.L.,
RA   Jensen L.J., Gnad F., Cox J., Jensen T.S., Nigg E.A., Brunak S., Mann M.;
RT   "Quantitative phosphoproteomics reveals widespread full phosphorylation
RT   site occupancy during mitosis.";
RL   Sci. Signal. 3:RA3-RA3(2010).
RN   [16]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=21269460; DOI=10.1186/1752-0509-5-17;
RA   Burkard T.R., Planyavsky M., Kaupe I., Breitwieser F.P., Buerckstuemmer T.,
RA   Bennett K.L., Superti-Furga G., Colinge J.;
RT   "Initial characterization of the human central proteome.";
RL   BMC Syst. Biol. 5:17-17(2011).
RN   [17]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-836, AND IDENTIFICATION BY
RP   MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=21406692; DOI=10.1126/scisignal.2001570;
RA   Rigbolt K.T., Prokhorova T.A., Akimov V., Henningsen J., Johansen P.T.,
RA   Kratchmarova I., Kassem M., Mann M., Olsen J.V., Blagoev B.;
RT   "System-wide temporal characterization of the proteome and phosphoproteome
RT   of human embryonic stem cell differentiation.";
RL   Sci. Signal. 4:RS3-RS3(2011).
RN   [18]
RP   HYDROXYLATION AT PRO-374; PRO-419 AND PRO-422 BY PHD3.
RX   PubMed=22797300; DOI=10.1172/jci62374;
RA   Xie L., Pi X., Mishra A., Fong G., Peng J., Patterson C.;
RT   "PHD3-dependent hydroxylation of HCLK2 promotes the DNA damage response.";
RL   J. Clin. Invest. 122:2827-2836(2012).
RN   [19]
RP   ACETYLATION [LARGE SCALE ANALYSIS] AT MET-1, AND IDENTIFICATION BY MASS
RP   SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=22814378; DOI=10.1073/pnas.1210303109;
RA   Van Damme P., Lasa M., Polevoda B., Gazquez C., Elosegui-Artola A.,
RA   Kim D.S., De Juan-Pardo E., Demeyer K., Hole K., Larrea E., Timmerman E.,
RA   Prieto J., Arnesen T., Sherman F., Gevaert K., Aldabe R.;
RT   "N-terminal acetylome analyses and functional insights of the N-terminal
RT   acetyltransferase NatB.";
RL   Proc. Natl. Acad. Sci. U.S.A. 109:12449-12454(2012).
RN   [20]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-836, AND IDENTIFICATION BY
RP   MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Erythroleukemia;
RX   PubMed=23186163; DOI=10.1021/pr300630k;
RA   Zhou H., Di Palma S., Preisinger C., Peng M., Polat A.N., Heck A.J.,
RA   Mohammed S.;
RT   "Toward a comprehensive characterization of a human cancer cell
RT   phosphoproteome.";
RL   J. Proteome Res. 12:260-271(2013).
RN   [21]
RP   IDENTIFICATION IN THE MTORC1 COMPLEX, IDENTIFICATION IN THE MTORC2 COMPLEX,
RP   SUBCELLULAR LOCATION, PHOSPHORYLATION AT SER-485; SER-487 AND SER-491,
RP   UBIQUITINATION, AND MUTAGENESIS OF SER-485.
RX   PubMed=23263282; DOI=10.1038/ncb2651;
RA   Fernandez-Saiz V., Targosz B.S., Lemeer S., Eichner R., Langer C.,
RA   Bullinger L., Reiter C., Slotta-Huspenina J., Schroeder S., Knorn A.M.,
RA   Kurutz J., Peschel C., Pagano M., Kuster B., Bassermann F.;
RT   "SCF(Fbxo9) and CK2 direct the cellular response to growth factor
RT   withdrawal via Tel2/Tti1 degradation and promote survival in multiple
RT   myeloma.";
RL   Nat. Cell Biol. 15:72-81(2013).
RN   [22]
RP   INVOLVEMENT IN YHFS, VARIANTS YHFS LEU-260; PHE-367; HIS-609; VAL-720 AND
RP   MET-766, AND CHARACTERIZATION OF VARIANTS YHFS PHE-367; VAL-720 AND
RP   MET-766.
RX   PubMed=27132593; DOI=10.1016/j.ajhg.2016.03.014;
RA   You J., Sobreira N.L., Gable D.L., Jurgens J., Grange D.K., Belnap N.,
RA   Siniard A., Szelinger S., Schrauwen I., Richholt R.F., Vallee S.E.,
RA   Dinulos M.B., Valle D., Armanios M., Hoover-Fong J.;
RT   "A syndromic intellectual disability disorder caused by variants in TELO2,
RT   a gene encoding a component of the TTT complex.";
RL   Am. J. Hum. Genet. 98:909-918(2016).
RN   [23]
RP   X-RAY CRYSTALLOGRAPHY (2.45 ANGSTROMS) OF 489-498 IN COMPLEX WITH PIH1D1,
RP   AND INTERACTION WITH PIH1D1.
RX   PubMed=24656813; DOI=10.1016/j.celrep.2014.03.013;
RA   Horejsi Z., Stach L., Flower T.G., Joshi D., Flynn H., Skehel J.M.,
RA   O'Reilly N.J., Ogrodowicz R.W., Smerdon S.J., Boulton S.J.;
RT   "Phosphorylation-dependent PIH1D1 interactions define substrate specificity
RT   of the R2TP cochaperone complex.";
RL   Cell Rep. 7:19-26(2014).
CC   -!- FUNCTION: Regulator of the DNA damage response (DDR). Part of the TTT
CC       complex that is required to stabilize protein levels of the
CC       phosphatidylinositol 3-kinase-related protein kinase (PIKK) family
CC       proteins. The TTT complex is involved in the cellular resistance to DNA
CC       damage stresses, like ionizing radiation (IR), ultraviolet (UV) and
CC       mitomycin C (MMC). Together with the TTT complex and HSP90 may
CC       participate in the proper folding of newly synthesized PIKKs. Promotes
CC       assembly, stabilizes and maintains the activity of mTORC1 and mTORC2
CC       complexes, which regulate cell growth and survival in response to
CC       nutrient and hormonal signals. May be involved in telomere length
CC       regulation. {ECO:0000269|PubMed:12670948, ECO:0000269|PubMed:20810650}.
CC   -!- SUBUNIT: Component of the TTT complex composed of TELO2, TTI1 and TTI2.
CC       Interacts with ATM, ATR, MTOR, PRKDC, RUVBL2, TTI1, TTI2, SMG1 and
CC       TRRAP. Component of the mTORC1 and mTORC2 complexes. Interacts
CC       (phosphorylated form) with PIH1D1 which mediates interaction of TELO2
CC       with the R2TP complex composed of RUVBL1, RUVBL2, PIH1D1, and RPAP3
CC       (PubMed:20864032, PubMed:24656813). {ECO:0000269|PubMed:20427287,
CC       ECO:0000269|PubMed:20801936, ECO:0000269|PubMed:20810650,
CC       ECO:0000269|PubMed:20864032, ECO:0000269|PubMed:23263282,
CC       ECO:0000269|PubMed:24656813}.
CC   -!- INTERACTION:
CC       Q9Y4R8; Q13315: ATM; NbExp=4; IntAct=EBI-1043674, EBI-495465;
CC       Q9Y4R8; P54252: ATXN3; NbExp=3; IntAct=EBI-1043674, EBI-946046;
CC       Q9Y4R8; Q9UK97: FBXO9; NbExp=5; IntAct=EBI-1043674, EBI-2869927;
CC       Q9Y4R8; Q9NWS0: PIH1D1; NbExp=14; IntAct=EBI-1043674, EBI-357318;
CC       Q9Y4R8; O43156: TTI1; NbExp=7; IntAct=EBI-1043674, EBI-1055680;
CC   -!- SUBCELLULAR LOCATION: Cytoplasm. Membrane. Nucleus. Chromosome,
CC       telomere {ECO:0000305}.
CC   -!- PTM: Hydroxylation by PHD3 is required for a proper interaction with
CC       ATR, and activation of the ATR/CHK1/p53 pathway following DNA damage.
CC       {ECO:0000269|PubMed:22797300}.
CC   -!- PTM: Phosphorylated at Ser-485 by CK2 following growth factor
CC       deprivation, leading to its subsequent ubiquitination by the SCF(FBXO9)
CC       complex. Phosphorylation by CK2 only takes place when TELO2 is bound to
CC       mTORC1, not mTORC2; leading to selective ubiquitination of mTORC1-
CC       associated protein. {ECO:0000269|PubMed:23263282}.
CC   -!- PTM: Ubiquitinated by the SCF(FBXO9) complex following phosphorylation
CC       by CK2 in response to growth factor deprivation, leading to its
CC       degradation by the proteasome. Only mTORC1-associated protein is
CC       ubiquitinated and degraded, leading to selective inactivation of mTORC1
CC       to restrain cell growth and protein translation, while mTORC2 is
CC       activated due to the relief of feedback inhibition by mTORC1.
CC       {ECO:0000269|PubMed:23263282}.
CC   -!- DISEASE: You-Hoover-Fong syndrome (YHFS) [MIM:616954]: A syndrome
CC       characterized by severe global developmental delay, intellectual
CC       disability, dysmorphic facial features, microcephaly, abnormal
CC       movements, congenital heart disease comprising developmental
CC       abnormalities of the great vessels, and abnormal auditory and visual
CC       function. The transmission pattern is consistent with autosomal
CC       recessive inheritance. {ECO:0000269|PubMed:27132593}. Note=The disease
CC       is caused by variants affecting the gene represented in this entry.
CC   -!- MISCELLANEOUS: Cells overexpressing TELO2 are hypersensitive to
CC       hydroxyurea (HU) and undergo apoptotic death in response to treatment
CC       with HU.
CC   -!- SIMILARITY: Belongs to the TEL2 family. {ECO:0000305}.
CC   -!- SEQUENCE CAUTION:
CC       Sequence=BAA31658.3; Type=Erroneous initiation; Note=Extended N-terminus.; Evidence={ECO:0000305};
CC   ---------------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   ---------------------------------------------------------------------------
DR   EMBL; AB014583; BAA31658.3; ALT_INIT; mRNA.
DR   EMBL; AL080126; CAB45724.1; -; mRNA.
DR   EMBL; AL137394; CAB70722.1; -; mRNA.
DR   EMBL; AE006467; AAK61284.1; -; Genomic_DNA.
DR   EMBL; AL031705; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; CH471112; EAW85647.1; -; Genomic_DNA.
DR   EMBL; CH471112; EAW85649.1; -; Genomic_DNA.
DR   EMBL; CH471112; EAW85650.1; -; Genomic_DNA.
DR   EMBL; BC017188; AAH17188.1; -; mRNA.
DR   CCDS; CCDS32363.1; -.
DR   PIR; T12514; T12514.
DR   RefSeq; NP_057195.2; NM_016111.3.
DR   RefSeq; XP_016879403.1; XM_017023914.1.
DR   PDB; 4PSI; X-ray; 2.45 A; D/E=489-498.
DR   PDBsum; 4PSI; -.
DR   SMR; Q9Y4R8; -.
DR   BioGRID; 115223; 78.
DR   ComplexPortal; CPX-6148; TTT complex.
DR   DIP; DIP-40568N; -.
DR   IntAct; Q9Y4R8; 55.
DR   MINT; Q9Y4R8; -.
DR   STRING; 9606.ENSP00000262319; -.
DR   iPTMnet; Q9Y4R8; -.
DR   PhosphoSitePlus; Q9Y4R8; -.
DR   BioMuta; TELO2; -.
DR   DMDM; 166987394; -.
DR   EPD; Q9Y4R8; -.
DR   jPOST; Q9Y4R8; -.
DR   MassIVE; Q9Y4R8; -.
DR   MaxQB; Q9Y4R8; -.
DR   PaxDb; Q9Y4R8; -.
DR   PeptideAtlas; Q9Y4R8; -.
DR   PRIDE; Q9Y4R8; -.
DR   ProteomicsDB; 86248; -.
DR   Antibodypedia; 23134; 117 antibodies.
DR   DNASU; 9894; -.
DR   Ensembl; ENST00000262319; ENSP00000262319; ENSG00000100726.
DR   GeneID; 9894; -.
DR   KEGG; hsa:9894; -.
DR   UCSC; uc002cly.4; human.
DR   CTD; 9894; -.
DR   DisGeNET; 9894; -.
DR   GeneCards; TELO2; -.
DR   HGNC; HGNC:29099; TELO2.
DR   HPA; ENSG00000100726; Low tissue specificity.
DR   MalaCards; TELO2; -.
DR   MIM; 611140; gene.
DR   MIM; 616954; phenotype.
DR   neXtProt; NX_Q9Y4R8; -.
DR   OpenTargets; ENSG00000100726; -.
DR   Orphanet; 488642; TELO2-related intellectual disability-neurodevelopmental disorder.
DR   PharmGKB; PA162405604; -.
DR   VEuPathDB; HostDB:ENSG00000100726.14; -.
DR   eggNOG; KOG4346; Eukaryota.
DR   GeneTree; ENSGT00390000006698; -.
DR   HOGENOM; CLU_008764_1_0_1; -.
DR   InParanoid; Q9Y4R8; -.
DR   OMA; DDEFIPY; -.
DR   OrthoDB; 355610at2759; -.
DR   PhylomeDB; Q9Y4R8; -.
DR   TreeFam; TF313925; -.
DR   PathwayCommons; Q9Y4R8; -.
DR   SIGNOR; Q9Y4R8; -.
DR   BioGRID-ORCS; 9894; 565 hits in 1005 CRISPR screens.
DR   ChiTaRS; TELO2; human.
DR   GeneWiki; TELO2; -.
DR   GenomeRNAi; 9894; -.
DR   Pharos; Q9Y4R8; Tbio.
DR   PRO; PR:Q9Y4R8; -.
DR   Proteomes; UP000005640; Chromosome 16.
DR   RNAct; Q9Y4R8; protein.
DR   Bgee; ENSG00000100726; Expressed in right hemisphere of cerebellum and 206 other tissues.
DR   ExpressionAtlas; Q9Y4R8; baseline and differential.
DR   Genevisible; Q9Y4R8; HS.
DR   GO; GO:0070209; C:ASTRA complex; IBA:GO_Central.
DR   GO; GO:0000781; C:chromosome, telomeric region; IEA:UniProtKB-SubCell.
DR   GO; GO:0005737; C:cytoplasm; IDA:UniProtKB.
DR   GO; GO:0005829; C:cytosol; IDA:HPA.
DR   GO; GO:0016020; C:membrane; IEA:UniProtKB-SubCell.
DR   GO; GO:0016604; C:nuclear body; IDA:HPA.
DR   GO; GO:0034399; C:nuclear periphery; IDA:UniProtKB.
DR   GO; GO:0005634; C:nucleus; IDA:UniProtKB.
DR   GO; GO:0031931; C:TORC1 complex; IDA:UniProtKB.
DR   GO; GO:0031932; C:TORC2 complex; IDA:UniProtKB.
DR   GO; GO:0051879; F:Hsp90 protein binding; IPI:UniProtKB.
DR   GO; GO:0060090; F:molecular adaptor activity; IEA:Ensembl.
DR   GO; GO:0019901; F:protein kinase binding; IPI:UniProtKB.
DR   GO; GO:0044877; F:protein-containing complex binding; IDA:MGI.
DR   GO; GO:0042162; F:telomeric DNA binding; IBA:GO_Central.
DR   GO; GO:0071902; P:positive regulation of protein serine/threonine kinase activity; IMP:UniProtKB.
DR   GO; GO:1904263; P:positive regulation of TORC1 signaling; IMP:UniProtKB.
DR   GO; GO:1904515; P:positive regulation of TORC2 signaling; IMP:UniProtKB.
DR   GO; GO:0050821; P:protein stabilization; IMP:UniProtKB.
DR   GO; GO:0032006; P:regulation of TOR signaling; IMP:UniProtKB.
DR   GO; GO:0007004; P:telomere maintenance via telomerase; IBA:GO_Central.
DR   Gene3D; 1.25.40.720; -; 1.
DR   InterPro; IPR016024; ARM-type_fold.
DR   InterPro; IPR038528; TEL2_sf.
DR   InterPro; IPR019337; Telomere_length_regulation_dom.
DR   Pfam; PF10193; Telomere_reg-2; 1.
DR   SUPFAM; SSF48371; SSF48371; 1.
PE   1: Evidence at protein level;
KW   3D-structure; Acetylation; Chromosome; Cytoplasm; Disease variant;
KW   Hydroxylation; Membrane; Mental retardation; Nucleus; Phosphoprotein;
KW   Reference proteome; Telomere; Ubl conjugation.
FT   CHAIN           1..837
FT                   /note="Telomere length regulation protein TEL2 homolog"
FT                   /id="PRO_0000318515"
FT   SITE            490
FT                   /note="Interaction with PIH1D1"
FT                   /evidence="ECO:0000250|UniProtKB:Q9DC40"
FT   SITE            491
FT                   /note="Interaction with PIH1D1"
FT                   /evidence="ECO:0000250|UniProtKB:Q9DC40"
FT   SITE            492
FT                   /note="Interaction with PIH1D1"
FT                   /evidence="ECO:0000250|UniProtKB:Q9DC40"
FT   MOD_RES         1
FT                   /note="N-acetylmethionine"
FT                   /evidence="ECO:0007744|PubMed:22814378"
FT   MOD_RES         374
FT                   /note="Hydroxyproline"
FT                   /evidence="ECO:0000269|PubMed:22797300"
FT   MOD_RES         419
FT                   /note="Hydroxyproline"
FT                   /evidence="ECO:0000269|PubMed:22797300"
FT   MOD_RES         422
FT                   /note="Hydroxyproline"
FT                   /evidence="ECO:0000269|PubMed:22797300"
FT   MOD_RES         456
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000250|UniProtKB:Q9DC40"
FT   MOD_RES         485
FT                   /note="Phosphoserine; by CK2"
FT                   /evidence="ECO:0000269|PubMed:23263282"
FT   MOD_RES         487
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000269|PubMed:23263282"
FT   MOD_RES         491
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000269|PubMed:23263282"
FT   MOD_RES         688
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0007744|PubMed:20068231"
FT   MOD_RES         836
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0007744|PubMed:21406692,
FT                   ECO:0007744|PubMed:23186163"
FT   VARIANT         7
FT                   /note="E -> G (in dbSNP:rs2667661)"
FT                   /id="VAR_038752"
FT   VARIANT         7
FT                   /note="E -> Q (in dbSNP:rs2667660)"
FT                   /id="VAR_061839"
FT   VARIANT         146
FT                   /note="Q -> R (in dbSNP:rs2235624)"
FT                   /evidence="ECO:0000269|PubMed:11230166,
FT                   ECO:0000269|PubMed:15489334, ECO:0000269|PubMed:17974005,
FT                   ECO:0000269|Ref.6"
FT                   /id="VAR_038753"
FT   VARIANT         260
FT                   /note="P -> L (in YHFS; dbSNP:rs369656775)"
FT                   /evidence="ECO:0000269|PubMed:27132593"
FT                   /id="VAR_077025"
FT   VARIANT         367
FT                   /note="C -> F (in YHFS; dbSNP:rs202020308)"
FT                   /evidence="ECO:0000269|PubMed:27132593"
FT                   /id="VAR_077026"
FT   VARIANT         511
FT                   /note="A -> V (in dbSNP:rs58099766)"
FT                   /id="VAR_061840"
FT   VARIANT         609
FT                   /note="R -> H (in YHFS; dbSNP:rs754162070)"
FT                   /evidence="ECO:0000269|PubMed:27132593"
FT                   /id="VAR_077027"
FT   VARIANT         674
FT                   /note="Q -> R (in dbSNP:rs2248128)"
FT                   /id="VAR_038754"
FT   VARIANT         720
FT                   /note="D -> V (in YHFS; dbSNP:rs878853271)"
FT                   /evidence="ECO:0000269|PubMed:27132593"
FT                   /id="VAR_077028"
FT   VARIANT         766
FT                   /note="V -> M (in YHFS; dbSNP:rs371675497)"
FT                   /evidence="ECO:0000269|PubMed:27132593"
FT                   /id="VAR_077029"
FT   MUTAGEN         485
FT                   /note="S->A: Abolishes phosphorylation by CK2 in response
FT                   to growth factor deprivation and subsequent ubiquitination
FT                   and degradation."
FT                   /evidence="ECO:0000269|PubMed:23263282"
FT   CONFLICT        7
FT                   /note="E -> R (in Ref. 1; BAA31658)"
FT                   /evidence="ECO:0000305"
SQ   SEQUENCE   837 AA;  91747 MW;  76CB619C73C1F1A7 CRC64;
     MEPAPSEVRL AVREAIHALS SSEDGGHIFC TLESLKRYLG EMEPPALPRE KEEFASAHFS
     PVLRCLASRL SPAWLELLPH GRLEELWASF FLEGPADQAF LVLMETIEGA AGPSFRLMKM
     ARLLARFLRE GRLAVLMEAQ CRQQTQPGFI LLRETLLGKV VALPDHLGNR LQQENLAEFF
     PQNYFRLLGE EVVRVLQAVV DSLQGGLDSS VSFVSQVLGK ACVHGRQQEI LGVLVPRLAA
     LTQGSYLHQR VCWRLVEQVP DRAMEAVLTG LVEAALGPEV LSRLLGNLVV KNKKAQFVMT
     QKLLFLQSRL TTPMLQSLLG HLAMDSQRRP LLLQVLKELL ETWGSSSAIR HTPLPQQRHV
     SKAVLICLAQ LGEPELRDSR DELLASMMAG VKCRLDSSLP PVRRLGMIVA EVVSARIHPE
     GPPLKFQYEE DELSLELLAL ASPQPAGDGA SEAGTSLVPA TAEPPAETPA EIVDGGVPQA
     QLAGSDSDLD SDDEFVPYDM SGDRELKSSK APAYVRDCVE ALTTSEDIER WEAALRALEG
     LVYRSPTATR EVSVELAKVL LHLEEKTCVV GFAGLRQRAL VAVTVTDPAP VADYLTSQFY
     ALNYSLRQRM DILDVLTLAA QELSRPGCLG RTPQPGSPSP NTPCLPEAAV SQPGSAVASD
     WRVVVEERIR SKTQRLSKGG PRQGPAGSPS RFNSVAGHFF FPLLQRFDRP LVTFDLLGED
     QLVLGRLAHT LGALMCLAVN TTVAVAMGKA LLEFVWALRF HIDAYVRQGL LSAVSSVLLS
     LPAARLLEDL MDELLEARSW LADVAEKDPD EDCRTLALRA LLLLQRLKNR LLPPASP
//
